1Wulffele MG, Kooy A, De Zeeuw D, et al. The efect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus; a systematic review. Br J Clin Pharmacol 2002;53(5):549.
2Seymour A, Glyburide/metformin HCI clinical overview. Manag Care 2001;10(2 Suupl) :11-16.
4Ratner RE. Controlling postprandial hyperglycemia. Am J Cardiol 2001;88(6A) :26.
5Sels JP, Huijberts MS, WOlffenbuttel BH. Miglitol, a new aplpha - glucosidase inhibitor. Expert Opin Pharmacother 1999;1(1):149.
6Cheng - Lai A, Levine A. Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes. Heart Dis 2000;2(4):326.
7Lebovitz HE. Oral therapies for diabetic hyperglycemia. Endocrinol Metab Clin North Am 2001;30(4) :909.
8Chilcott J, Tappenden P, Jones ML. et al. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. Clin Ther 2001 Nov; 23 (11) : 1792.
9Asian - Pacific Type 2 Diabetes Policy Group. Type 2 diabetes practical targets and treatment(Third edition) 2002: 19.
